home / stock / imab / imab quote
Last: | $1.76 |
---|---|
Change Percent: | -2.55% |
Open: | $1.81 |
Close: | $1.76 |
High: | $1.83 |
Low: | $1.76 |
Volume: | 126,368 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.76 | $1.81 | $1.76 | $1.83 | $1.76 | 126,368 | 05-03-2024 |
$1.765 | $1.79 | $1.765 | $1.79 | $1.76 | 96,975 | 05-02-2024 |
$1.765 | $1.77 | $1.765 | $1.815 | $1.73 | 119,766 | 05-01-2024 |
$1.77 | $1.79 | $1.77 | $1.81 | $1.7609 | 147,654 | 04-30-2024 |
$1.8 | $1.8 | $1.8 | $1.84 | $1.8 | 225,338 | 04-29-2024 |
$1.8 | $1.81 | $1.8 | $1.83 | $1.7999 | 88,595 | 04-26-2024 |
$1.81 | $1.8 | $1.81 | $1.81 | $1.78 | 283,718 | 04-25-2024 |
$1.81 | $1.81 | $1.81 | $1.82 | $1.795 | 109,542 | 04-24-2024 |
$1.8 | $1.8 | $1.8 | $1.83 | $1.795 | 204,957 | 04-23-2024 |
$1.8 | $1.81 | $1.8 | $1.811 | $1.79 | 143,848 | 04-22-2024 |
$1.8 | $1.8 | $1.8 | $1.85 | $1.79 | 335,382 | 04-19-2024 |
$1.8 | $1.8 | $1.8 | $1.83 | $1.785 | 137,472 | 04-18-2024 |
$1.81 | $1.8 | $1.81 | $1.86 | $1.79 | 389,712 | 04-17-2024 |
$1.79 | $1.8 | $1.79 | $1.83 | $1.78 | 235,411 | 04-16-2024 |
$1.8 | $1.81 | $1.8 | $1.8316 | $1.79 | 404,065 | 04-15-2024 |
$1.81 | $1.8 | $1.81 | $1.84 | $1.78 | 264,153 | 04-12-2024 |
$1.81 | $1.81 | $1.81 | $1.83 | $1.79 | 124,179 | 04-11-2024 |
$1.82 | $1.8 | $1.82 | $1.83 | $1.77 | 222,784 | 04-10-2024 |
$1.8 | $1.8 | $1.8 | $1.825 | $1.785 | 131,586 | 04-09-2024 |
$1.81 | $1.87 | $1.81 | $1.87 | $1.785 | 215,151 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
I-MAB Company Name:
IMAB Stock Symbol:
NASDAQ Market:
I-MAB Filed 2023 Annual Report on Form 20-F PR Newswire ROCKVILLE, Md. , April 30, 2024 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of...
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference PR Newswire ROCKVILLE, Md. , April 5, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercializa...
I-Mab Announces Closing of the Divestiture of Business Operations in China PR Newswire ROCKVILLE, Md. , April 2, 2024 /PRNewswire/ -- I-Mab (the " Company ") (NASDAQ: IMAB) a U.S.-based, global biotech company, exclusively focused on the development and ...